Costimulatory Effects of T Cell Proliferation during Infection with Human T Lymphotropic Virus Types I and II Are Mediated Through CD80 and CD86 Ligands

Journal of Immunology

Volumn 157, Issue 3, 1996, Pages 1288-1296

  Lal, Renu B ^a,d   Rudolph, Donna L ^a   Dezzutti, Charlene S ^a   Linsley, Peter S ^b   Prince, Harry E ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c AMERICAN RED CROSS BLOOD SERVICES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BIOSYNTHESIS; CELL DIVISION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; MALE; T LYMPHOCYTE; VIROLOGY;

ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL DIVISION; FEMALE; FLOW CYTOMETRY; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030210375     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Matsuya, H., H-G. Guo, J. Cossman, H. Megson, M. S. Reitz, and S. Broder. 1984. Functional properties of antigen-specific T cells infected by human T cell leukemia/lymphoma virus (HTLV-1). Science 225:1484.
2. Höllesberg, P., and D. A. Hafler. 1993. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173.
3. Casse, H., Y. Girerd, L. Gazzolo, and M. DucDodon. 1994. Critical involvement of human T cell leukemia virus type I virions in mediating the viral mitogenic effect. J. Gen. Virol. 75:1909.
4. Wucherpfennig, K. W., P. Höllsberg, J. H. Richardson, D. Benjamin, and D. A. Hafler. 1992. T cell activation by autologous human T cell leukemia virus type I-infected T cell clones. Proc. Natl. Acad. Sci. USA 89:2110.
5. Höllesberg, P., K. W. Wucherpfennig, L. J. Aususel, V. Calvo, B. E. Bierer, and D. A. Hafler. 1992. Characterization of HTLV-1 in vivo infected T cell clones: IL-2-independent growth of nontransformed T cells. J. Immunol. 148:3256.
6. Mann, D. L., P. Martin, G. Hamlin-Green, R. Nalewalk, and W. A. Blattner. 1994. Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes. Clin. Immunol. Immunopathol. 72:312.
7. Prince, H. E., J. York, J. Golding, S. M. Owen, and R. B. Lal. 1994. Spontaneous lymphocyte proliferation in HTLV-I and HTLV-II infection: T cell subset responses and their relationships to presence of provirus and viral antigen production. Clin. Diag. Lab. Immunol. 1:273.
8. Tendler, C. L., S. J. Greenberg, W. A. Blattner, A. Manns, E. Murphy, T. Fleisher, B. Hanchard, O. Morgan, J. D. Burton, D. L. Nelson, and T. A. Waldmann. 1990. Transactivation of interleukin 2 and its receptor induces immune activation of human T cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA 87:5218.
9. Kimata, J. T., and L. Ratner. 1991. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65:4398.
10. Lal, R. B., B. Hjelle, and D. L. Rudolph. 1992. Spontaneous proliferation of HTLV-II-infected peripheral blood lymphocytes: HLA-DR-driven, IL-2-dependent response. Microbiol. Immunol. 36:865.
11. Kimata, J. T., T. J. Palker, and L. Ratner. 1993. The mitogenic activity of human T cell leukemia virus type I is T cell associated and requires the CD2/LFA-3 activation pathway. J. Virol. 67:3134.
12. Dezzutti, C. S., D. L. Rudolph, and R. B. Lal. 1994. Modulation of HTLV-II-associated spontaneous lymphocyte proliferation by β2 integrin CD11a/CD18 involves interaction with its cognate ligand, CD54. Cell. Immunol. 156:113.
13. Kimata, J. T., F-H. Wong, and L. Ratner. 1994. CD3-dependent lymphocyte activation by human T cell leukemia virus type I-producing T cells. J. Gen. Virol. 75:2433.
14. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
15. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
16. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigens. Annu. Rev. Immunol. 11:191.
17. + T cells. J. Exp. Med. 173:759.
18. + T lymphocytes. J. Immunol. 148:665.
19. Williams, T. M., D. M. Moolten, H. Makni, H. W. Kim, J. A. Kant, and M. Kamoun. 1992. CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporin-A sensitive. J. Immunol. 148: 2609.
20. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. M. Nadler, and L. H. Glimcher. 1992. Signaling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266.
21. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, and L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:845.
22. Sansom, D. M., and N. D. Hall. 1993. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol. 23:295.
23. Wyss-Coray, T., D. Mauri-Hellweg, K. Baumann, F. Bettens, R. Grunow, and W. J. Pichler. 1993. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23: 2175.
24. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
25. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
26. Linsley, P. S. 1995. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182:289.
27. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
28. Dezzutti, C. S., D. L. Rudolph, and R. B. Lal. 1995. Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T cell counterreceptors CD40, CD54 and CD80 (B7-1). Clin. Diag. Lab. Immunol. 2:349.
29. Kitamura, H., D. L. Rudolph, C. Goldsmith, T. M. Folks, and R. B. Lal. 1993. Isolation, characterization, and transmission of human T-lymphotropic virus types I and II in culture. Curr. Microbiol. 27:355.
30. Dezzutti, C. S., D. L. Rudolph, C. R. Roberts, and R. B. Lal. 1993. Characterization of human T-lymphotropic virus type I- and II-infected T cell lines: antigenic, phenotypic, and genotypic analysis. Virus Res. 29:59.
31. Bhat, N. K., Y. Adachi, K. P. Samuel, and D. Derse. 1993. HTLV-1 gene expression by defective proviruses in an infected T cell line. Virology 196:15.
32. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 co-stimulates primary allogeneic proliferative response and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
33. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
34. Engel, P., J. G. Gribben, G. J. Freeman, L-J. Zhou, Y. Nozawa, M. Abe, L. M. Nadler, H. Wakasa, and T. F. Tedder. 1994. The B7-2 (B70) costimulatory molecule expressed by monocyte and activated B lymphocytes is the CD86 differentiation antigen. Blood 84:1402.
35. Valle, A., P. Garrone, H. Yssel, J-Y. Bonnefoy, A. S. Freedman, G. Freeman, L. M. Nadler, and J. Banchereau. 1989. mAb 104, a new monoclonal antibody recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology 69:531.
36. Wyss-Coray, T., H. Gallati, I. Pracht, A. Limat, D. Mauri, K. Frutig, and W. J. Pichler. 1993. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones. Eur. J. Immunol. 23: 3350.
37. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:211.
38. Chen, C., and N. Nabavi. 1994. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1:147.
39. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
40. Freeman, G. J., D. B. Lombard, C. D. Gimmi, S. A. Brod, K. Lee, J. C. Laning, D. A. Hafler, M. E. Dorf, G. S. Gray, H. Reiser, C. H. June, C. B. Thompson, and L. M. Nadler. 1992. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation: expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 149:3795.
41. + T lymphocytes during HIV-1 infection. J. Acquired Immune Defic. Syndr. 7:245.
42. + T cells from human immunodeficiency virus type 1-infected donors. Proc. Natl. Acad. Sci. USA 90:11094.
43. Nickoloff, B. J., F. O. Nestle, X-G. Zheng, and L. A. Turka. 1994. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Blood 83:2580.
44. Verwilghen, J., R. Lovis, M. D. Boer, P. S. Linsley, G. K. Haines, A. E. Koch, and R. M. Pope. 1994. Expression of functional B7 and CTLA-4 on rheumatoid synovial T cells. J. Immunol. 153:1378.
45. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
46. Gribben, J. G., G. J. Freeman, V. A. Bousiotis, P. Rennet, C. L. Jellis, E. Greenfield, M. Barber, V. A. Restivo Jr., X. Ke, G. S. Gray, and L. M. Nadler. 1995. CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811.
47. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J. Exp. Med. 182: 2890.
48. Pichler, W. J., and T. Wyss-Coray. 1994. T cells as antigen-presenting cells. Immunol. Today 15:312.
49. Damle, N. K., K. Klussman, P. S. Linsley, A. Aruffo, and J. A. Ledbetter. 1992. Differential regulatory effects of intracellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J. Immunol. 149:2541.
50. Boussiotis, V. A., G. J. Freeman, G. Gray, J. Gribben, and L. M. Nadler. 1993. B7 but not intracellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178:1753.
51. Lal, R. B., D. L. Rudolph, T. Rowe, and T. M. Folks. 1992. Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals. J. Clin. Immunol. 12:75.
52. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1:317.
53. Baum, P. R., R. B. Gayle, F. Ramsdell, S. Srinivasan, R. A. Sorenson, M. L. Watson, M. F. Seldin, E. Baker, G. R. Sutherland, K. N. Clifford, M. R. Alderson, R. G. Goodwin, and W. C. Fanslow. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-I-regulated protein gp34. EMBO J. 13:3992.
54. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180:757.